Observable data points shared across all narratives
Authorities have recorded the first seizure of etomidate e-liquid following its classification as a controlled substance. This development marks increased regulatory enforcement on new drug formulations, affecting manufacturers, distributors, and consumers involved with etomidate products. The seizure highlights the challenges in controlling emerging drug delivery methods.